Urologie pro praxi 4/2016
Immunotherapy for prostate cancer
Prostate cancer is one of the most common cancers in men. Advances in the field of molecular immunology are leading to a deeper understanding of the interactions between the immune system and cancer, allowing identification of new targets in the immune system and resulting in the development of new anticancer agents. Immunotherapy is emerging as another promising treatment modality in prostate cancer in addition to classic hormonal therapy, radiotherapy and chemotherapy. The aim of this review is to present an overview of current immunotherapeutic approaches, which are being clinically tested in the management of prostate cancer.
Keywords: prostate cancer, immune system, immunotherapy
